Primary packaging for wearable injection devices
Download the whitepaper to explore primary packaging for wearable injection devices!
Patients have used pens and autoinjectors at home to treat chronic conditions like diabetes and rheumatoid arthritis for quite some time. Home administration of novel biological drugs presents many challenges. Subcutaneous injection of viscous biologic drugs is possible if injected in high volumes or over a longer duration. A new drug delivery platform has gained wide attention in the industry to achieve this.
Read this whitepaper to get an overview of existing wearable injector solutions and new requirements, with a focus on the role of the primary packaging inside the devices!
The article was initially published in OndrugDelivery in 2019.
Patients have used pens and autoinjectors at home to treat chronic conditions like diabetes and rheumatoid arthritis for quite some time. Home administration of novel biological drugs presents many challenges. Subcutaneous injection of viscous biologic drugs is possible if injected in high volumes or over a longer duration. A new drug delivery platform has gained wide attention in the industry to achieve this.
Read this whitepaper to get an overview of existing wearable injector solutions and new requirements, with a focus on the role of the primary packaging inside the devices!
The article was initially published in OndrugDelivery in 2019.
